Ali Tas - RTA Laboratuvarlari Vice Chairman of the Board
| RTALB Stock | TRY 13.20 0.52 4.10% |
Chairman
Mr. Ali Tas is Vice Chairman of the Board of RTA Laboratuvarlari Biyolojik Ilac ve Makine Sanayi Ticaret AS. He is a Founding Partner of the Company
| Professional Marks | Ph.D |
| Phone | 90 262 648 53 00 |
| Web | https://www.rtalabs.com.tr |
RTA Laboratuvarlari Management Efficiency
The company has return on total asset (ROA) of 0.0138 % which means that it generated a profit of $0.0138 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5211 %, meaning that it generated $0.5211 on every $100 dollars invested by stockholders. RTA Laboratuvarlari's management efficiency ratios could be used to measure how well RTA Laboratuvarlari manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | CHAIRMAN Age | ||
| Himmet Karadag | Turkiye Halk Bankasi | 44 | |
| Hasan Cebeci | Turkiye Halk Bankasi | 65 | |
| Ali Koc | Yapi ve Kredi | 52 | |
| Suzan Dincer | Akbank TAS | N/A | |
| Ramazan Gunduz | Turkiye Vakiflar Bankasi | 64 | |
| Suleyman Kalkan | Turkiye Halk Bankasi | 58 | |
| Mehmet Ozcan | Turkiye Vakiflar Bankasi | 57 | |
| Eyup Engin | Turk Telekomunikasyon AS | N/A | |
| Agah Tara | ENKA Insaat ve | 40 | |
| Hakki Ozince | Turkiye Is Bankasi | 65 | |
| Mohammed Hariri | Turk Telekomunikasyon AS | 58 | |
| Fuat Oktay | Turk Telekomunikasyon AS | 53 | |
| Carlo Vivaldi | Yapi ve Kredi | 53 | |
| Gokhan Erun | Yapi ve Kredi | 55 | |
| Hayri Culhaci | Akbank TAS | N/A | |
| Ersin Ozince | Turkiye Is Bankasi | 63 | |
| Omer Sayan | Turk Telekomunikasyon AS | 41 | |
| Adnan Bali | Turkiye Is Bankasi | 56 | |
| Ozcan | Akbank TAS | N/A | |
| Kemal Madenoglu | Turk Telekomunikasyon AS | 51 | |
| Haluk Gercek | ENKA Insaat ve | 62 | |
Management Performance
| Return On Equity | 0.52 | |||
| Return On Asset | 0.0138 |
RTA Laboratuvarlari Leadership Team
Elected by the shareholders, the RTA Laboratuvarlari's board of directors comprises two types of representatives: RTA Laboratuvarlari inside directors who are chosen from within the company, and outside directors, selected externally and held independent of RTA. The board's role is to monitor RTA Laboratuvarlari's management team and ensure that shareholders' interests are well served. RTA Laboratuvarlari's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, RTA Laboratuvarlari's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Tayyip Turkaslan, Member of the Board | ||
| Alev Kahraman, Production Manager | ||
| Arzu Gunaydin, Director of Sales - Animal Health | ||
| Gokhan Celikelli, Member of the Board | ||
| Sinan Levent, Director of Sales - Medical Products - Microbiology | ||
| Ahmet Baris, Director of Sales - Medical Products - Molecular Biology | ||
| Bilgen Yusufoglu, Vice General Manager | ||
| Guven Akat, Finance Director | ||
| Ali Tas, Vice Chairman of the Board | ||
| Bahadir Akdemir, Director of Research & Development | ||
| Gven Akat, Fin Director | ||
| Tahsin Yesildere, Member of the Board | ||
| Resat Ultav, Chairman of the Board, General Manager |
RTA Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is RTA Laboratuvarlari a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.52 | |||
| Return On Asset | 0.0138 | |||
| Profit Margin | 1.10 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 100 M | |||
| Shares Owned By Insiders | 29.39 % | |||
| Shares Owned By Institutions | 0.10 % | |||
| Price To Earning | 5.85 X | |||
| Price To Book | 2.44 X |
Currently Active Assets on Macroaxis
| LAAC | Lithium Americas Corp | |
| F | Ford Motor | |
| CHPT | ChargePoint Holdings | |
| AXL | American Axle Manufacturing | |
| ICLN | iShares Global Clean |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RTA Laboratuvarlari Biyolojik. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the RTA Laboratuvarlari information on this page should be used as a complementary analysis to other RTA Laboratuvarlari's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for RTA Stock analysis
When running RTA Laboratuvarlari's price analysis, check to measure RTA Laboratuvarlari's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RTA Laboratuvarlari is operating at the current time. Most of RTA Laboratuvarlari's value examination focuses on studying past and present price action to predict the probability of RTA Laboratuvarlari's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RTA Laboratuvarlari's price. Additionally, you may evaluate how the addition of RTA Laboratuvarlari to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |